Oncolytics Biotech (ONCY) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Oncolytics Biotech (ONCY) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Oncolytics Biotech

· ONCY

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

86.006 M

-0.93%

General

Market Cap: $86.01M
Enterprise Value: $91.82M
Shares Outstanding: 119,350,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -498.10%
ROE: 1020.21%
ROIC: -1480.50%
Current Ratio: 1.35
Debt-to-Equity: -0.07
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -2.41

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $26.86M
Operating Income: -$26.86M
Net Profit: -$26.83M

Balance Sheet

Cash and Equivalents: $2.89M
Working Capital: $1.29M
Total Assets: $5.39M
Net Debt: -$2.57M
Total Liabilities: $9.72M
Total Equity: -$4.33M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$20.31M
Cash Flow from Investing: -$8.63K
Cash Flow from Financing: $15.62M
Free Cash Flow: -$20.32M
Capital Expenditures: $8.85K